[HTML][HTML] Phosphorylated tau in Alzheimer's disease and other tauopathies

P Rawat, U Sehar, J Bisht, A Selman… - International Journal of …, 2022 - mdpi.com
Alzheimer's disease (AD) is the leading cause of dementia in elderly people. Amyloid beta
(Aβ) deposits and neurofibrillary tangles are the major pathological features in an …

Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications

M Nimgampalle, H Chakravarthy, S Sharma… - Ageing Research …, 2023 - Elsevier
Neurotransmitters serve as chemical messengers playing a crucial role in information
processing throughout the nervous system, and are essential for healthy physiological and …

[HTML][HTML] Molecular pathophysiological mechanisms in Huntington's disease

A Jurcau - Biomedicines, 2022 - mdpi.com
Huntington's disease is an inherited neurodegenerative disease described 150 years ago
by George Huntington. The genetic defect was identified in 1993 to be an expanded CAG …

Mitochondrial HSF1 triggers mitochondrial dysfunction and neurodegeneration in Huntington's disease

C Liu, Z Fu, S Wu, X Wang, S Zhang, C Chu… - EMBO Molecular …, 2022 - embopress.org
Aberrant localization of proteins to mitochondria disturbs mitochondrial function and
contributes to the pathogenesis of Huntington's disease (HD). However, the crucial factors …

Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease

S Kshirsagar, N Sawant, H Morton, AP Reddy… - Pharmacological …, 2021 - Elsevier
The purpose of our study is to determine the protective effects of mitophagy enhancers
against phosphorylated tau (P-tau)-induced mitochondrial and synaptic toxicities in …

HD and SCA1: Tales from two 30-year journeys since gene discovery

LM Thompson, HT Orr - Neuron, 2023 - cell.com
One of the more transformative findings in human genetics was the discovery that the
expansion of unstable nucleotide repeats underlies a group of inherited neurological …

[HTML][HTML] Mitochondria in Huntington's disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies

A Jurcau, CM Jurcau - Neural Regeneration Research, 2023 - journals.lww.com
Huntington's disease is a genetic disease caused by expanded CAG repeats on exon 1 of
the huntingtin gene located on chromosome 4. Compelling evidence implicates impaired …

Mitophagy regulation in aging and neurodegenerative disease

TA Banarase, SS Sammeta, NL Wankhede… - Biophysical …, 2023 - Springer
Mitochondria are the primary cellular energy generators, supplying the majority of
adenosine triphosphate through oxidative phosphorylation, which is necessary for neuron …

[HTML][HTML] Altered exocytosis of inhibitory synaptic vesicles at single presynaptic terminals of cultured striatal neurons in a knock-in mouse model of Huntington's disease

C Xu, S Chen, X Chen, KH Ho, C Park… - Frontiers in Molecular …, 2023 - frontiersin.org
Huntington's disease (HD) is a progressive dominantly inherited neurodegenerative disease
caused by the expansion of a cytosine-adenine-guanine (CAG) trinucleotide repeat in the …

[HTML][HTML] Mitochondrial proteotoxicity: implications and ubiquitin-dependent quality control mechanisms

M Karbowski, Y Oshima, N Verhoeven - Cellular and Molecular Life …, 2022 - Springer
Through their role in energy generation and regulation of several vital pathways, including
apoptosis and inflammation, mitochondria are critical for the life of eukaryotic organisms …